These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2439250)

  • 1. Clinical and biochemical effects during treatment of depression with nortriptyline: the role of 10-hydroxynortriptyline.
    Nordin C; Bertilsson L; Siwers B
    Clin Pharmacol Ther; 1987 Jul; 42(1):10-9. PubMed ID: 2439250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF and plasma levels of nortriptyline and its 10-hydroxy metabolite.
    Nordin C; Bertilsson L; Siwers B
    Br J Clin Pharmacol; 1985 Oct; 20(4):411-3. PubMed ID: 4074608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of depression with E-10-hydroxynortriptyline--a pilot study on biochemical effects and pharmacokinetics.
    Nordin C; Bertilsson L; Dahl ML; Resul B; Toresson G; Sjöqvist F
    Psychopharmacology (Berl); 1991; 103(3):287-90. PubMed ID: 2057534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin uptake inhibition during treatment of depression with nortriptyline caused by parent drug and not by 10-hydroxymetabolites.
    Malmgren R; Aberg-Wistedt A; Bertilsson L
    Psychopharmacology (Berl); 1987; 92(2):169-72. PubMed ID: 2440073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective efflux of (E)-10-hydroxynortriptyline enantiomers from the cerebrospinal fluid of depressed patients.
    Bertilsson L; Otani K; Dahl ML; Nordin C; Aberg-Wistedt A
    Pharmacol Toxicol; 1991 Feb; 68(2):100-3. PubMed ID: 1852713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma 10-hydroxynortriptyline in elderly depressed patients.
    Young RC; Alexopoulos GS; Shamoian CA; Manley MW; Dhar AK; Kutt H
    Clin Pharmacol Ther; 1984 Apr; 35(4):540-4. PubMed ID: 6705454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline.
    Nordin C; Bertilsson L
    Clin Pharmacokinet; 1995 Jan; 28(1):26-40. PubMed ID: 7712660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine treatment of depressive disorders. Clinical and biochemical effects.
    Nordin C; Siwers B; Bertilsson L
    Acta Psychiatr Scand; 1981 Jul; 64(1):25-33. PubMed ID: 6172006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF/plasma ratio of 10-hydroxynortriptyline is influenced by sex and body height.
    Nordin C
    Psychopharmacology (Berl); 1993; 113(2):222-4. PubMed ID: 7855185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isomers of 10-hydroxynortriptyline in geriatric depression.
    Young RC; Dhar AK; Kutt H; Alexopoulos GS
    Ther Drug Monit; 1988; 10(2):164-7. PubMed ID: 3381232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of nortriptyline and 10-hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed.
    McCue RE; Georgotas A; Nagachandran N; Abdul Basir M; Go EA; Suckow RF; Cooper TB
    J Psychiatr Res; 1989; 23(1):73-9. PubMed ID: 2754630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nortriptyline response in elderly depressed patients.
    Kanba S; Matsumoto K; Nibuya M; Suzuki E; Kinoshita N; Shintani F; Yagi G
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 May; 16(3):301-9. PubMed ID: 1589587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma 10-hydroxynortriptyline and therapeutic response in geriatric depression.
    Young RC; Alexopoulos GS; Shindledecker R; Dhar AK; Kutt H
    Neuropsychopharmacology; 1988 Sep; 1(3):213-5. PubMed ID: 3251501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of single oral doses of E-10-hydroxynortriptyline in healthy subjects, with some observations on pharmacodynamic effects.
    Bertilsson L; Nordin C; Otani K; Resul B; Scheinin M; Siwers B; Sjöqvist F
    Clin Pharmacol Ther; 1986 Sep; 40(3):261-7. PubMed ID: 3742932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of depression with tricyclic drugs--pharmacokinetic and pharmacodynamic aspects.
    Asberg M
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):18-26. PubMed ID: 10583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verbal memory and plasma drug concentrations in elderly depressives treated with nortriptyline.
    Young RC; Mattis S; Alexopoulos GS; Meyers BS; Shindledecker RD; Dhar AK
    Psychopharmacol Bull; 1991; 27(3):291-4. PubMed ID: 1775601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 10-Hydroxynortriptyline and treatment effects in elderly depressed patients.
    McCue RE; Georgotas A; Suckow RF; Cooper TB
    J Neuropsychiatry Clin Neurosci; 1989; 1(2):176-80. PubMed ID: 2521060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients--relationship to the debrisoquine hydroxylation metabolic ratio.
    Nordin C; Siwers B; Benitez J; Bertilsson L
    Br J Clin Pharmacol; 1985 Jun; 19(6):832-5. PubMed ID: 4027124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype.
    Dahl ML; Bertilsson L; Nordin C
    Psychopharmacology (Berl); 1996 Feb; 123(4):315-9. PubMed ID: 8867869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype.
    Gram LF; Brøsen K; Kragh-Sørensen P; Christensen P
    Ther Drug Monit; 1989 Sep; 11(5):508-14. PubMed ID: 2815225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.